Technical Analysis for DYN - Dyne Therapeutics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 50 DMA Resistance | Bearish | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 2.29% | |
| Gapped Up | Strength | 2.29% | |
| Oversold Stochastic | Weakness | 2.29% | |
| Stochastic Buy Signal | Bullish | 6.62% | |
| Spinning Top | Other | 6.62% | |
| Lower Bollinger Band Walk | Weakness | 6.62% | |
| Lower Bollinger Band Touch | Weakness | 6.62% |
| Alert | Time |
|---|---|
| 50 DMA Resistance | about 18 hours ago |
| Up 5% | about 19 hours ago |
| 60 Minute Opening Range Breakout | about 19 hours ago |
| Rose Above 50 DMA | about 19 hours ago |
| Up 3% | about 20 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Dyne Therapeutics is building a leading muscle disease company focused on advancing innovative life-transforming therapeutics for patients with genetically driven diseases. The Company utilizes its proprietary FORCE™ platform to overcome the current limitations of muscle tissue delivery with modern oligonucleotide therapeutic candidates. Dyne is developing a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD) and facioscapulohumeral muscular dystrophy (FSHD).
Sector: Healthcare
Industry: Biotechnology
Keywords: Disease Medical Genetics Dystrophy Muscular Dystrophy Oligonucleotide Duchenne Muscular Dystrophy Duchenne Myotonic Dystrophy Genetic Genealogy Dystrophin Facioscapulohumeral Muscular Dystrophy Muscle Disease Muscle Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Disease Medical Genetics Dystrophy Muscular Dystrophy Oligonucleotide Duchenne Muscular Dystrophy Duchenne Myotonic Dystrophy Genetic Genealogy Dystrophin Facioscapulohumeral Muscular Dystrophy Muscle Disease Muscle Diseases
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 30.2687 |
| 52 Week Low | 6.4 |
| Average Volume | 1,377,177 |
| 200-Day Moving Average | 15.37 |
| 50-Day Moving Average | 25.97 |
| 20-Day Moving Average | 26.40 |
| 10-Day Moving Average | 25.28 |
| Average True Range | 1.61 |
| RSI (14) | 47.92 |
| ADX | 20.08 |
| +DI | 21.87 |
| -DI | 23.96 |
| Chandelier Exit (Long, 3 ATRs) | 24.97 |
| Chandelier Exit (Short, 3 ATRs) | 27.94 |
| Upper Bollinger Bands | 29.40 |
| Lower Bollinger Band | 23.41 |
| Percent B (%b) | 0.34 |
| BandWidth | 22.71 |
| MACD Line | -0.44 |
| MACD Signal Line | -0.12 |
| MACD Histogram | -0.3221 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 27.69 | ||||
| Resistance 3 (R3) | 27.74 | 27.03 | 27.31 | ||
| Resistance 2 (R2) | 27.03 | 26.46 | 27.01 | 27.19 | |
| Resistance 1 (R1) | 26.24 | 26.11 | 26.63 | 26.19 | 27.06 |
| Pivot Point | 25.53 | 25.53 | 25.73 | 25.51 | 25.53 |
| Support 1 (S1) | 24.74 | 24.96 | 25.14 | 24.69 | 23.82 |
| Support 2 (S2) | 24.03 | 24.61 | 24.01 | 23.69 | |
| Support 3 (S3) | 23.24 | 24.03 | 23.57 | ||
| Support 4 (S4) | 23.19 |
